Professor Kelly Chibale awarded honorary fellowship by the Royal Society of Chemistry

Global health scientist and leading medicinal chemist, Professor Kelly Chibale, has attained the prestigious status of Honorary Fellow from the Royal Society of Chemistry (RSC), marking a significant milestone in the recognition of his pioneering work in pharmaceutical research and scientific capacity building within Africa.

Professor Chibale, based at the University of Cape Town, holds the distinguished Neville Isdell Chair in African-centric Drug Discovery and Development. He founded the Holistic Drug Discovery and Development (H3D) Centre, Africa's first fully integrated drug discovery platform, which is dedicated to the advancement of new medicines addressing infectious diseases like malaria and tuberculosis—ailments that heavily impact African populations.

Under Professor Chibale's leadership, H3D has significantly contributed to the early stages of drug development, including the notable achievement of the first African antimalarial drug candidate to enter Phase I clinical trials.This development not only signifies a leap forward in combating infectious diseases but also reinforces the potential of African-led initiatives in the global pharmaceuticals industry.

The Honorary Fellowship awarded to Professor Chibale is the highest honour conferred by the RSC, celebrating individuals whose scientific endeavours place them at the forefront of advancing the chemical sciences and benefiting society at large. With this accolade, Professor Chibale joins an esteemed cohort of leading global figures in chemistry, including several Nobel laureates and trailblazers in the field.

Dr Annette Doherty, President of the RSC, commended Professor Chibale for his invaluable contributions, stating, “He exemplifies the transformative impact of chemistry on society. His work has reshaped our understanding of the potential of chemistry to provide solutions to pressing global health challenges.”

Professor Chibale's journey from rural Zambia to becoming a global leader in medicinal chemistry is inspiring for many aspiring scientists across Africa, underscoring the message that groundbreaking science can emerge from any context.

Beyond his direct contributions to drug discovery, Professor Chibale is an ardent advocate for equity, inclusion, and opportunity within the scientific community. He has devoted considerable efforts to mentor early-career researchers, especially those from underrepresented backgrounds, fostering pathways to elite research, international collaborations, and leadership in science.

His influence also extends to policy advocacy and public engagement, as he engages in discourse around the role of chemistry in economic development and job creation. Recognised for his societal contributions, Professor Chibale was listed among Fortune Magazine’s “World’s 50 Greatest Leaders” in 2018.

This year, Professor Chibale is one of seven individuals to receive this recognition—the largest cohort since 2017—and he will be formally celebrated during the RSC’s annual Summer Party in London this coming July. Other honourees include renowned figures such as Professor Carolyn R. Bertozzi and Sir Demis Hassabis, reflecting a significant gathering of scientific excellence.